NOVN.CH

96.47

-0.26%↓

LONN.CH

546.4

+0.04%↑

SDZ.CH

47.94

+2.3%↑

STMN.CH

90.88

+0.04%↑

BANB.CH

63.9

+1.67%↑

NOVN.CH

96.47

-0.26%↓

LONN.CH

546.4

+0.04%↑

SDZ.CH

47.94

+2.3%↑

STMN.CH

90.88

+0.04%↑

BANB.CH

63.9

+1.67%↑

NOVN.CH

96.47

-0.26%↓

LONN.CH

546.4

+0.04%↑

SDZ.CH

47.94

+2.3%↑

STMN.CH

90.88

+0.04%↑

BANB.CH

63.9

+1.67%↑

NOVN.CH

96.47

-0.26%↓

LONN.CH

546.4

+0.04%↑

SDZ.CH

47.94

+2.3%↑

STMN.CH

90.88

+0.04%↑

BANB.CH

63.9

+1.67%↑

NOVN.CH

96.47

-0.26%↓

LONN.CH

546.4

+0.04%↑

SDZ.CH

47.94

+2.3%↑

STMN.CH

90.88

+0.04%↑

BANB.CH

63.9

+1.67%↑

Strona główna・Stock List・Roche Holding AG

Roche Holding AG

Closed

SectorHealthcare

273.8 0.66

Buy Sell

Overview

Share price change

24h

Current

Min

270.6

Max

273.8

Key metrics
By Trading Economics
Income	1.7B 3.7B
Sales	-15B 16B
P/E Sector Avg	23.37 35.293
Dividend yield	3.47
Profit margin	23.266
Employees	103,249
EBITDA	547M 6.5B

Dividends
By Dow Jones
Dividend yield Sector Avg	3.47% 3.07%

Market Stats
By TradingEconomics
Market Cap	3.2B 209B
Previous open	273.14
Previous close	273.8

News Sentiment

By Acuity

19%

81%

40 / 371 Ranking in Healthcare

Roche Holding AG Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

24 lip 2025, 15:09 UTC

Earnings

Roche Weighs Selling Drugs Directly to Patients in Bid to Lower U.S. Prices -- Update

24 lip 2025, 05:36 UTC

Earnings

Roche Backs 2025 Views After Strong Sales of Key Drugs

11 cze 2025, 08:25 UTC

Acquisitions, Mergers, Takeovers

EQT, Sanofi Co-Led $135 Million Funding Round for Spanish Biotech Company SpliceBio

12 maj 2025, 02:16 UTC

Major Market Movers

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

24 kwi 2025, 07:30 UTC

Earnings

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

24 kwi 2025, 05:31 UTC

Earnings

Roche Sales Rise Boosted By Key Drugs

8 sie 2025, 10:51 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Novartis's Midterm Prospects Look Better Than Roche's -- Market Talk

8 sie 2025, 07:39 UTC

Market Talk

Earnings

Roche Could Reach Peak Earnings Growth This Year -- Market Talk

5 sie 2025, 10:40 UTC

Market Talk

Roche, Novartis Face Limited Tariff Headwinds for Now -- Market Talk

24 lip 2025, 06:52 UTC

Market Talk

Earnings

Roche Looks Confident in a Tricky Environment -- Market Talk

24 lip 2025, 05:05 UTC

Earnings

Roche Backs 2025 View

24 lip 2025, 05:05 UTC

Earnings

Correct: Roche 1H Diagnostics Sales Down 3%, Reported

24 lip 2025, 05:04 UTC

Earnings

Correct: Roche 1H Sales Rose 4% On Year , Reported

24 lip 2025, 05:04 UTC

Earnings

Roche 1H Net Pft Was Seen at CHF8.4B

24 lip 2025, 05:04 UTC

Earnings

Roche 1H Net Pft CHF7.8B

24 lip 2025, 05:03 UTC

Earnings

Roche 1H Oper Pft CHF12.0B

24 lip 2025, 05:03 UTC

Earnings

Roche 1H Diagnostics Sales Down 3% at Constant Currency

24 lip 2025, 05:03 UTC

Earnings

Roche 1H Sales Rose 4% On Year at Constant Currency

24 lip 2025, 05:02 UTC

Earnings

Roche 1H Sales CHF30.9B , In Line With Analyst Views

21 lip 2025, 06:44 UTC

Market Talk

Roche Drug Candidate Disappoints in Lung Disease Trials -- Market Talk

16 cze 2025, 08:55 UTC

Hot Stocks

Stocks to Watch: Victoria's Secret, Renault, U.S. Steel, Sarepta -- WSJ

3 cze 2025, 07:51 UTC

Market Talk

Roche Unlikely to Get Revenue Boost From Tecentriq Combination With Lurbinectedin -- Market Talk

21 maj 2025, 07:20 UTC

Market Talk

Roche Lymphoma Drug Columvi Dealt Setback by FDA Committee -- Market Talk

2 maj 2025, 06:25 UTC

Market Talk

Earnings

Roche Shows Pipeline Progress But Near-Term Risks Remain -- Market Talk

24 kwi 2025, 09:39 UTC

Market Talk

Earnings

Roche's Pipeline in Focus After Solid Results -- Market Talk

24 kwi 2025, 09:24 UTC

Market Talk

Earnings

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

24 kwi 2025, 09:18 UTC

Market Talk

Earnings

Roche's Results Are Solid -- Market Talk

24 kwi 2025, 05:16 UTC

Peer Comparison

Price change

Roche Holding AG Forecast

Sentiment

By Acuity

40 / 371 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.